Nanovista
PrivateLast Round
Grant
Apr 1, 2020
Total Funding Raised
$1.89M
Company Overview
Nanovista operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in April 2020.
Nanovista is a biotechnology company that develops multimodal visualization agents designed to enhance image-guided high-precision cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanovista Comparables
Compare Nanovista with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zoobug | 84% | |
| Tomato Glasses | 82% | |
| ClearVision Optical | 77% |
For institutional investors. Book with your work email.
Nanovista Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2020 | ||||
| Grant | Sep 3, 2018 | ||||
| Seed | Feb 14, 2018 |
For institutional investors. Book with your work email.
Nanovista Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreenSky Ventures | Seed |
| National Research Council Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
| Johnson & Johnson Innovation - JLABS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2020
$7K grant received from NRC IRAP.
- Sep 3, 2018
$84K grant from National Research Council Canada Industrial Research Assistance Program.
For institutional investors. Book with your work email.
Nanovista Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanovista's valuation, stock price, and market status.
Is Nanovista a public or private company?
Nanovista is a private company.
What is the current stock price of Nanovista?
Nanovista is a private company, so its shares have no public market price. Caplight tracks Nanovista's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanovista worth (valuation)?
Valuation information for Nanovista is not publicly available.
Can I buy Nanovista stock?
Nanovista shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanovista's last funding round?
Nanovista's most recent funding round was Grant on April 1, 2020.
Who are the main investors in Nanovista?
Key investors in Nanovista include GreenSky Ventures, National Research Council Canada Industrial Research Assistance Program (NRC IRAP).
Will Nanovista IPO soon?
No public IPO plans have been announced for Nanovista.
How can I track Nanovista secondary market activity?
Caplight tracks bids, offers, and trades in Nanovista's shares on secondary markets.